A Study of Niraparib in Patients With Relapsed Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ge Lou
Harbin Medical University
Principal Investigator - Hong Zheng
Peking University Cancer Hospital & Institute
Principal Investigator - Hongmin Pan
Sir Run Shaw Hospital, school of medicine, Zhejiang University
Principal Investigator - Lingying Wu
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator - Rutie Yin
West China Second University Hospital
Principal Investigator - Xiaohua Wu
Fudan University
Principal Investigator - Zhongqiu Lin
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- Sun Yat-Sen Memorial Hospital,sun Yat-Sen University
Guangzhou, Guangdong, China
- Harbin Medical University
Haerbin, Heilongjiang, China
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- West China Second Iniversity Hospital
Chengdu, Sichuan, China
- Sir Run Shaw Hospital, School of Medicine, Zhejiang University
Guangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Aug 2020
- Primary completion
- 8 Apr 2021
- Completion
- 11 Aug 2022
- Last update posted
- 29 Aug 2022
- Registered enrollment
- 15
- Registry id
- NCT04392102
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.